CN Stock MarketDetailed Quotes

688278 Xiamen Amoytop Biotech

Watchlist
  • 70.91
  • -0.49-0.69%
Market Closed Dec 20 15:00 CST
28.85BMarket Cap38.94P/E (TTM)

Xiamen Amoytop Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
21.53%419.31M
34.86%1.53B
41.17%1.14B
52.35%714.87M
Operating revenue
33.90%1.95B
31.68%1.19B
30.05%545.3M
37.55%2.1B
27.69%1.46B
26.40%903.58M
21.53%419.31M
34.86%1.53B
41.17%1.14B
52.35%714.87M
Total operating cost
30.42%1.3B
27.57%816.75M
24.66%379.69M
23.30%1.44B
14.73%996.11M
17.68%640.25M
17.61%304.58M
27.66%1.16B
37.93%868.24M
47.16%544.04M
Operating cost
38.79%129.93M
23.73%78.97M
0.09%37.77M
-17.24%140.05M
-23.25%93.62M
-14.77%63.82M
3.11%37.73M
35.25%169.24M
56.10%121.97M
62.07%74.88M
Operating tax surcharges
21.45%9.61M
26.78%6.12M
31.27%2.79M
43.30%11.24M
40.40%7.91M
37.43%4.83M
33.38%2.13M
37.25%7.84M
38.74%5.63M
42.17%3.51M
Operating expense
29.13%777.95M
20.99%499.73M
29.96%241.91M
20.71%848.8M
10.21%602.43M
15.81%413.04M
7.31%186.14M
17.67%703.15M
29.01%546.63M
46.56%356.67M
Administration expense
24.79%190.15M
43.78%119.45M
29.70%54.39M
51.98%210.31M
58.10%152.37M
40.23%83.08M
49.70%41.94M
34.11%138.38M
43.17%96.38M
50.51%59.24M
Financial expense
39.54%-1.86M
17.61%-1.42M
30.08%-750.94K
-15.10%-4.81M
8.94%-3.08M
20.35%-1.73M
-3.25%-1.07M
-282.73%-4.18M
-472.87%-3.38M
-592.79%-2.17M
-Interest expense (Financial expense)
-3.77%357.36K
-8.10%229.42K
-2.77%114.11K
-18.46%506.17K
-25.11%371.36K
-28.61%249.63K
-37.44%117.36K
-42.23%620.73K
48.02%495.87K
--349.65K
-Interest Income (Financial expense)
51.36%-2.33M
42.52%-1.79M
25.64%-975.13K
-45.04%-6.63M
-34.96%-4.79M
-24.37%-3.11M
4.18%-1.31M
-60.22%-4.57M
-93.75%-3.55M
-151.77%-2.5M
Research and development
35.34%193.34M
47.53%113.91M
15.55%43.58M
53.48%229.98M
41.44%142.86M
48.74%77.21M
85.34%37.71M
83.83%149.84M
77.66%101.01M
34.39%51.91M
Credit Impairment Loss
11.81%-547.47K
88.74%-113.8K
135.01%127.38K
-132.95%-463.8K
13.87%-620.78K
-518.11%-1.01M
-1,028.37%-363.79K
-39.22%1.41M
-167.33%-720.71K
-113.54%-163.51K
Asset Impairment Loss
----
----
----
---12.76M
----
----
----
----
----
----
Other net revenue
Fair value change income
689.64%1.29M
708.65%865.58K
----
566.55%2.65M
-86.27%163.84K
-76.82%107.04K
----
-77.89%397.64K
-76.67%1.19M
-87.58%461.71K
Invest income
1.13%2.28M
-11.91%1.67M
-26.34%1.4M
0.74%3.55M
5.72%2.26M
5.52%1.9M
47.80%1.9M
-29.38%3.52M
2,523.70%2.14M
2,106.53%1.8M
Asset deal income
456.60%45.5K
941.82%44.95K
--44.95K
-90.80%8.84K
-91.49%8.17K
-94.34%4.31K
----
216.07%96.06K
364.21%96.06K
302.42%76.21K
Other revenue
-6.00%14.29M
125.39%9.72M
21.96%3.33M
-40.87%22.98M
-55.84%15.2M
-85.99%4.31M
68.24%2.73M
102.70%38.87M
591.13%34.42M
754.84%30.8M
Operating profit
40.00%672.95M
43.41%385.24M
43.30%170.52M
67.28%680.72M
54.03%480.68M
31.82%268.64M
33.69%118.99M
63.73%406.92M
62.92%312.08M
88.40%203.79M
Add:Non operating Income
129.28%641.07K
119.43%533.53K
188.13%501.72K
47.52%453.06K
182.29%279.61K
241.61%243.14K
310.17%174.13K
85.15%307.12K
-18.93%99.05K
134.88%71.17K
Less:Non operating expense
-16.39%27.84M
-9.20%20.18M
-10.58%13.65M
-21.02%40.52M
-26.15%33.29M
-22.88%22.22M
-7.43%15.26M
53.57%51.31M
68.59%45.08M
72.53%28.82M
Total profit
44.25%645.75M
48.22%365.6M
51.46%157.37M
80.00%640.65M
67.61%447.67M
40.91%246.66M
43.19%103.9M
65.33%355.93M
61.93%267.09M
91.32%175.05M
Less:Income tax cost
16.30%91.6M
37.72%61.26M
44.77%28.56M
23.65%85.21M
18.11%78.77M
7.45%44.48M
30.58%19.73M
102.16%68.91M
79.03%66.69M
113.47%41.39M
Net profit
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
Net profit from continuing operation
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
Net profit of parent company owners
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
Earning per share
Basic earning per share
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
50.00%0.21
57.78%0.71
58.06%0.49
83.33%0.33
Diluted earning per share
49.45%1.36
50.00%0.75
52.38%0.32
92.96%1.37
85.71%0.91
51.52%0.5
50.00%0.21
57.78%0.71
58.06%0.49
83.33%0.33
Other composite income
Total composite income
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
Total composite income of parent company owners
50.21%554.15M
50.53%304.34M
53.03%128.81M
93.52%555.45M
84.08%368.91M
51.27%202.18M
46.51%84.17M
58.40%287.02M
56.95%200.41M
85.36%133.65M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
--
Rong Cheng Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M21.53%419.31M34.86%1.53B41.17%1.14B52.35%714.87M
Operating revenue 33.90%1.95B31.68%1.19B30.05%545.3M37.55%2.1B27.69%1.46B26.40%903.58M21.53%419.31M34.86%1.53B41.17%1.14B52.35%714.87M
Total operating cost 30.42%1.3B27.57%816.75M24.66%379.69M23.30%1.44B14.73%996.11M17.68%640.25M17.61%304.58M27.66%1.16B37.93%868.24M47.16%544.04M
Operating cost 38.79%129.93M23.73%78.97M0.09%37.77M-17.24%140.05M-23.25%93.62M-14.77%63.82M3.11%37.73M35.25%169.24M56.10%121.97M62.07%74.88M
Operating tax surcharges 21.45%9.61M26.78%6.12M31.27%2.79M43.30%11.24M40.40%7.91M37.43%4.83M33.38%2.13M37.25%7.84M38.74%5.63M42.17%3.51M
Operating expense 29.13%777.95M20.99%499.73M29.96%241.91M20.71%848.8M10.21%602.43M15.81%413.04M7.31%186.14M17.67%703.15M29.01%546.63M46.56%356.67M
Administration expense 24.79%190.15M43.78%119.45M29.70%54.39M51.98%210.31M58.10%152.37M40.23%83.08M49.70%41.94M34.11%138.38M43.17%96.38M50.51%59.24M
Financial expense 39.54%-1.86M17.61%-1.42M30.08%-750.94K-15.10%-4.81M8.94%-3.08M20.35%-1.73M-3.25%-1.07M-282.73%-4.18M-472.87%-3.38M-592.79%-2.17M
-Interest expense (Financial expense) -3.77%357.36K-8.10%229.42K-2.77%114.11K-18.46%506.17K-25.11%371.36K-28.61%249.63K-37.44%117.36K-42.23%620.73K48.02%495.87K--349.65K
-Interest Income (Financial expense) 51.36%-2.33M42.52%-1.79M25.64%-975.13K-45.04%-6.63M-34.96%-4.79M-24.37%-3.11M4.18%-1.31M-60.22%-4.57M-93.75%-3.55M-151.77%-2.5M
Research and development 35.34%193.34M47.53%113.91M15.55%43.58M53.48%229.98M41.44%142.86M48.74%77.21M85.34%37.71M83.83%149.84M77.66%101.01M34.39%51.91M
Credit Impairment Loss 11.81%-547.47K88.74%-113.8K135.01%127.38K-132.95%-463.8K13.87%-620.78K-518.11%-1.01M-1,028.37%-363.79K-39.22%1.41M-167.33%-720.71K-113.54%-163.51K
Asset Impairment Loss ---------------12.76M------------------------
Other net revenue
Fair value change income 689.64%1.29M708.65%865.58K----566.55%2.65M-86.27%163.84K-76.82%107.04K-----77.89%397.64K-76.67%1.19M-87.58%461.71K
Invest income 1.13%2.28M-11.91%1.67M-26.34%1.4M0.74%3.55M5.72%2.26M5.52%1.9M47.80%1.9M-29.38%3.52M2,523.70%2.14M2,106.53%1.8M
Asset deal income 456.60%45.5K941.82%44.95K--44.95K-90.80%8.84K-91.49%8.17K-94.34%4.31K----216.07%96.06K364.21%96.06K302.42%76.21K
Other revenue -6.00%14.29M125.39%9.72M21.96%3.33M-40.87%22.98M-55.84%15.2M-85.99%4.31M68.24%2.73M102.70%38.87M591.13%34.42M754.84%30.8M
Operating profit 40.00%672.95M43.41%385.24M43.30%170.52M67.28%680.72M54.03%480.68M31.82%268.64M33.69%118.99M63.73%406.92M62.92%312.08M88.40%203.79M
Add:Non operating Income 129.28%641.07K119.43%533.53K188.13%501.72K47.52%453.06K182.29%279.61K241.61%243.14K310.17%174.13K85.15%307.12K-18.93%99.05K134.88%71.17K
Less:Non operating expense -16.39%27.84M-9.20%20.18M-10.58%13.65M-21.02%40.52M-26.15%33.29M-22.88%22.22M-7.43%15.26M53.57%51.31M68.59%45.08M72.53%28.82M
Total profit 44.25%645.75M48.22%365.6M51.46%157.37M80.00%640.65M67.61%447.67M40.91%246.66M43.19%103.9M65.33%355.93M61.93%267.09M91.32%175.05M
Less:Income tax cost 16.30%91.6M37.72%61.26M44.77%28.56M23.65%85.21M18.11%78.77M7.45%44.48M30.58%19.73M102.16%68.91M79.03%66.69M113.47%41.39M
Net profit 50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M
Net profit from continuing operation 50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M
Net profit of parent company owners 50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M
Earning per share
Basic earning per share 49.45%1.3650.00%0.7552.38%0.3292.96%1.3785.71%0.9151.52%0.550.00%0.2157.78%0.7158.06%0.4983.33%0.33
Diluted earning per share 49.45%1.3650.00%0.7552.38%0.3292.96%1.3785.71%0.9151.52%0.550.00%0.2157.78%0.7158.06%0.4983.33%0.33
Other composite income
Total composite income 50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M
Total composite income of parent company owners 50.21%554.15M50.53%304.34M53.03%128.81M93.52%555.45M84.08%368.91M51.27%202.18M46.51%84.17M58.40%287.02M56.95%200.41M85.36%133.65M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Rong Cheng Certified Public Accountants (Special General Partnership)------Rong Cheng Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Virus Prevention
Virus Prevention
Intraday+0.60%